Page last updated: 2024-08-24

zileuton and Bronchospasm, Exercise-Induced

zileuton has been researched along with Bronchospasm, Exercise-Induced in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valacer, DJ1
Dickerson, KS; Luttermoser, GK; Scow, DT1
Bleecker, ER; Cohn, J; Hasday, JD; Meltzer, SS1

Reviews

2 review(s) available for zileuton and Bronchospasm, Exercise-Induced

ArticleYear
New treatments for asthma: the role of leukotriene modifier agents.
    Journal of the National Medical Association, 1999, Volume: 91, Issue:8 Suppl

    Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Asthma, Exercise-Induced; Cyclopropanes; Drug Evaluation; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome

1999
Leukotriene inhibitors in the treatment of allergy and asthma.
    American family physician, 2007, Jan-01, Volume: 75, Issue:1

    Topics: Acetates; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Cyclopropanes; Dermatitis, Atopic; Humans; Hydroxyurea; Hypersensitivity; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides; Sulfonamides; Tosyl Compounds

2007

Trials

1 trial(s) available for zileuton and Bronchospasm, Exercise-Induced

ArticleYear
Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor.
    American journal of respiratory and critical care medicine, 1996, Volume: 153, Issue:3

    Topics: Adult; Albuterol; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchial Spasm; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Forced Expiratory Volume; Humans; Hydroxyurea; Inflammation Mediators; Leukotriene Antagonists; Leukotriene B4; Leukotriene C4; Leukotrienes; Lipoxygenase Inhibitors; Vital Capacity

1996